In a post hoc analysis of the LIBERTY ASTHMA QUEST study, researchers found that dupilumab may reduce exacerbations in patients with allergic bronchopulmonary aspergillosis.
Ragweed sublingual immunotherapy tablet improved symptoms and decreased the need for rescue medication in the largest allergy immunotherapy trial in children with ragweed allergic rhinitis with or without conjunctivitis.
High-dose peanut oral immunotherapy provided similar or greater efficacy than other previously reported forms of peanut oral immunotherapy without additional safety concerns.
Asthma plus atopic dermatitis may lead to poorer sleep-specific outcomes in pediatric patients.
The oral biologic drug AR101 has demonstrated consistent efficacy and safety in providing oral peanut immunotherapy to patients with peanut allergy and sensitization.
A diverse maternal diet during pregnancy, especially among mothers who have a history of allergic disease, is associated with lower rates of eczema and/or food allergies in infant offspring.
A population-based survey found that adverse quality of life due to food allergies was more common among individuals in lower income brackets and in younger age groups, as well as in those with greater education.
The oral plasma kallikrein inhibitor, BCX7353, reduced hereditary angioedema attacks during a 24-week treatment period.